RecruitingNCT07574645
Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry
SPIDER - Spinal Dural Arteriovenous Fistula International Data and Outcomes Registry
Sponsor
Thomas Jefferson University
Enrollment
1,000 participants
Start Date
Jan 5, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
Given the lack of large multicenter datasets in the context of Spinal arteriovenous fistula, the strength of the evidence surrounding this rare disease is limited. SPIDER hence aims to address that by compiling patient-level data from centers all around the world.
Eligibility
Inclusion Criteria3
- Type 1 spinal dural arteriovenous fistula, confirmed on imaging
- Surgically or endovascularly treated
- At least 1 available primary outcome
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07574645